Posts filtered by tags: Andrew Dunn[x]


 

Scientists are aiming to launch a nationwide trial 'as soon as possible' to find out if the top coronavirus vaccines can stop the virus from spreading

A 16-year-old participates in Pfizer's clinical trial to test its coronavirus vaccine candidate. Cincinnati Children’s Hospital Massive studies have shown that two leading coronavirus vaccines are highly effective at preventing people from getting sick with COVID-19, the disease caused by the coronavirus. Top researchers are already pitching plans for additional studies, Business Insider has learned. This research aims to answer a critical question: can these experimental shots also pr...
Tags: Science, US, Trends, Healthcare, Philadelphia, University of Pennsylvania, Pfizer, University Of North Carolina, Cohen, Corey, UNC, Children s Hospital, National Cancer Institute, Paul Offit, NCI, Lowy


AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

A man walking past an AstraZeneca sign in Macclesfield, England. Phil Noble/Reuters The UK pharmaceutical company AstraZeneca is likely to run a second global trial to assess its COVID-19 vaccine's efficacy, its CEO told Bloomberg News on Thursday. AstraZeneca and the University of Oxford announced Monday that preliminary results indicated their two-dose vaccine could be up to 90% effective at preventing COVID-19. But the team later said an error in the trial left some participants with...
Tags: Health, UK, Science, News, Politico, US, Trends, South Africa, Brazil, Astrazeneca, Pfizer, University of Oxford, Pascal Soriot, Bloomberg News, Moderna, Siphiwe Sibeko


AstraZeneca will likely re-test its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results

A man walks past a sign at an AstraZeneca site in Macclesfield, UK. Phil Noble/Reuters UK pharmaceutical company AstraZeneca will likely run a second global trial to assess its COVID-19 vaccine's efficacy, the CEO told Bloomberg News on Thursday. AstraZeneca and the University of Oxford announced Monday that preliminary results showed their two-dose vaccine could be up to 90% effective at preventing COVID-19. But the team later admitted that there was an error in the trial, leaving some...
Tags: Health, UK, Science, News, US, Trends, Brazil, Astrazeneca, Pfizer, University of Oxford, Pascal Soriot, Bloomberg News, Soweto South Africa, Moderna, Siphiwe Sibeko, Sheila Bird


6 crucial questions about AstraZeneca's vaccine

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,Happy day-before-Thanksgiving! It's seeming like a pretty good time to log off and relax. For those looking for some holiday specific content, I was reminiscing this morning on some of my classic early BI stories. They include such gems as: how to have a (nutritionally) ...
Tags: Cdc, Trends, Getty Images, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Business Insider, Cb Insights, Soweto South Africa, Moderna, Andrew Dunn, Jenner Institute


6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results

A lower initial dose of the Oxford-AstraZeneca vaccine, would mean double the number of vaccine doses available, once regulators approve it. VINCENZO PINTO/AFP via Getty Images For the third consecutive Monday, a drugmaker said its coronavirus vaccine candidate was successful in late-stage studies. AstraZeneca and the University of Oxford said their two-dose shot was effective at preventing COVID-19, according to preliminary results.  AstraZeneca's news follows similar announcements of suc...
Tags: Health, UK, Science, US, Trends, Getty Images, Analysis, Healthcare, Oxford, Brazil, Astrazeneca, Pfizer, University of Oxford, Biotech, Afp, Pollard


A 3rd coronavirus vaccine works

Hollis Johnson/Business Insider Hello,Another Monday, another batch of vaccine results. This time: AstraZeneca and the University of Oxford shared that their coronavirus vaccine was 70% effective on average. That comes on the heels of Pfizer and its partner BioNTech and Moderna both sharing last week that their coronavirus vaccines were 95% and 94.5% effective, respectively. Moncef Slaoui, the scientific head of Operation Warp Speed, is anticipating things will move quickly from here. He s...
Tags: Science, Massachusetts, US, Trends, Atlantic, Healthcare, Argentina, Astrazeneca, National Institutes of Health, Fda, Pfizer, Vaccine, University of Oxford, Oxford University, Santa, Donald Trump


Pfizer just asked the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore receiving an injection. University of Maryland School of Medicine/AP Photo Pfizer and BioNTech requested that the US Food and Drug Administration review their coronavirus vaccine for emergency authorization, they announced Friday. The vaccine was found to be 95% effective at preventing COVID-19 in a late-stage trial. The FDA has said it might ...
Tags: News, US, Trends, Healthcare, Fda, Pfizer, Baltimore, Centers For Disease Control And Prevention, Reuters, US Food and Drug Administration, Baylor College of Medicine, University of Maryland School of Medicine, Moderna, Andrew Dunn, BioNtech, Albert Bourla


The latest on the march toward a successful coronavirus vaccine

Hollis Johnson/Business Insider Hello, It feels so dissonant — the good news about vaccines working at the same time as case counts are rising even higher, New York's shutting down its schools, and states and cities are making the tough decisions to lock back down in the hopes of mitigating even further spread of the virus. But that's indeed where we find ourselves in November 2020. How's everyone holding up? Has anyone restarted a hobby? My sourdough starter's back from hibernation as par...
Tags: Amazon, New York, Trends, Bill Gates, World Health Organization, Fda, Pfizer, Biden, Morgan Stanley, University Of Maryland, PillPack, Andrew, Blake, Shelby, Gilead, Vivek Murthy


Pfizer is about to ask the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people

The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. University of Maryland School of Medicine/AP Photo Pfizer and BioNTech are about to request that the US Food and Drug Administration review their coronavirus vaccine for emergency authorization. The vaccine was 95% effective at preventing COVID-19 in a late-stage trial. The FDA has said it might take weeks to review the...
Tags: News, US, Trends, Healthcare, Fda, Pfizer, Baltimore, Centers For Disease Control And Prevention, Reuters, US Food and Drug Administration, Baylor College of Medicine, University of Maryland School of Medicine, Moderna, Andrew Dunn, BioNtech, Allana Akhtar


Moderna and Pfizer's coronavirus vaccines are more than 94% effective. Here's how that compares to shots for flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer reported Wednesday that its coronavirus vaccine candidate was found to be 95% effective in preventing COVID-19 in clinical trials. Moderna's vaccine candidate was found to be 94.5% effective in trials. The chart below shows how the efficacy of those vaccine candidates compares to the effectiveness of...
Tags: Health, Science, News, Nbc, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Astrazeneca, Pfizer, Anthony Fauci, Johnson Johnson, Moderna, Andrew Dunn, BioNtech


Pfizer's coronavirus shot is 95% effective

Hollis Johnson/Business Insider Hello,In an update Wednesday, Pfizer and its partner BioNTech said their coronavirus vaccine was 95% effective at preventing COVID-19, after a larger analysis of 170 cases of the disease seen in the study.Of those 170 cases, 162 occurred in participants who received placebo shots, not the experimental vaccine. Read more about the updated results here.Next up: Pfizer said it'll be filing for emergency authorization "within days."Also today in healthcare news:...
Tags: Amazon, Microsoft, Washington Post, Washington, US, Trends, New York Times, Dolly Parton, Bill Gates, Pfizer, Gates, Johnson Johnson, Reuters Amazon, Hollis Johnson, Jeff Pachoud, Moderna


Pfizer says its coronavirus vaccine is 95% effective as it gears up to ask the FDA to authorize the shot

A health care worker injects a patient with a syringe of an experimental coronavirus vaccine. Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer's coronavirus vaccine candidate was 95% effective at protecting people against COVID-19, the pharmaceutical giant said in a Wednesday press release. Pfizer shared preliminary results from this late-stage study on November 9. Wednesday's release provided more details that come from the trial's final efficacy analysis. Pfizer began developin...
Tags: Health, Science, US, Trends, Healthcare, Fda, Pfizer, Biotech, Trump, US Food and Drug Administration, EUA, Pharmaceutical, Moderna, Peter Marks, Andrew Dunn, BioNtech


Bill Gates says several more COVID-19 vaccine frontrunners will likely be highly effective, boosting worldwide access to a shot

Jeff Pachoud/AFP/Getty Images Success from two leading coronavirus vaccine programs likely means other frontrunners will also show strong protection against COVID-19, Bill Gates said Tuesday. Drug companies Pfizer and Moderna both announced late-stage success with their COVID-19 vaccines in the past 10 days. The billionaire Microsoft founder and philanthropist said that bodes well for other experimental shots. "With the very good news from Pfizer and Moderna, we think it's now likely that...
Tags: Health, Science, Microsoft, Trends, New York Times, Bill Gates, Healthcare, Astrazeneca, Pfizer, Gates, Johnson & Johnson, J J, Andrew Ross Sorkin, Novavax, Jeff Pachoud, Moderna


When can I get a coronavirus vaccine?

Jakub Porzycki/NurPhoto via Getty Images Both Moderna and Pfizer have recently delivered promising news that their coronavirus vaccines are highly effective, in large, diverse human trials. But that doesn't mean you're going to be able to get a shot before the end of 2020.  In all likelihood, the first coronavirus vaccines will begin rolling out to frontline workers and vulnerable populations in the last days of 2020, or possibly early 2021. By Memorial Day in late May, it's possible that...
Tags: Science, News, Cdc, White House, US, Trends, Public Health, South Africa, New York Times, Vaccination, Fda, Pfizer, Anthony Fauci, Istanbul, Soweto, Ankara Turkey


It'll take weeks to vet a COVID-19 vaccine

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,If coronavirus vaccine results weren't quite enough breaking news for you this week, Amazon has officially unveiled its long-awaited Amazon Pharmacy service, selling prescription medications and offering discount services for Prime members. Much like Amazon's original fo...
Tags: Amazon, Trends, Walgreens, Bill Gates, Healthcare, Food And Drug Administration, Miami, Philadelphia, Fda, Pfizer, Vaccines, Morgan Stanley, Anthony Fauci, Nih, Business Insider, Trump


Moderna and Pfizer's coronavirus vaccines are more than 90% effective. Here's how that compares to shots for the flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images Moderna announced Monday that its coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials. Pfizer announced last week that its coronavirus vaccine candidate was found to be more than 90% effective. The chart below shows how those vaccine candidates' efficacy c...
Tags: Health, Science, News, Nbc, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Vaccines, Anthony Fauci, Johnson Johnson, Moderna


Meet Stéphane Bancel, the CEO of Moderna, a company developing a coronavirus vaccine in record time that is showing early signs of success in a preliminary study

Moderna CEO Stephane Bancel attends 2019 Forbes Healthcare Summit at the Jazz at Lincoln Center on Dec. 5, 2019 in New York City. Steven Ferdman/Getty Images Stéphane Bancel is the CEO of Moderna, the company that translated the genetic code of the coronavirus into a vaccine. Moderna released results on Monday that said its vaccine is 94.5% effective in preventing COVID-19; human trials began in March. It typically takes several years to develop a vaccine.  The vaccine uses messenger RNA, ...
Tags: France, White House, Massachusetts, New York City, US, Trends, Strategy, Features, Healthcare, Fda, Pfizer, Vaccine, Lincoln Center, Biotech, Donald Trump, Biotechnology


Moderna's coronavirus vaccine requires 2 shots given a month apart, which makes it tougher to get everyone fully inoculated

A nurse prepares a coronavirus vaccine developed by Moderna and the National Institutes of Health, July 2020. Hans Pennink/AP Moderna announced Monday that its coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials. The vaccine requires two shots administered four weeks apart, which could make distribution more complicated. People may need additional booster shots later, experts say. Visit Business Insider's homepage for more stories. Two co...
Tags: Health, Science, News, Massachusetts, Trends, Turkey, Astrazeneca, National Institutes of Health, Pfizer, Anthony Fauci, Mount Sinai, Boston Globe, Johnson Johnson, Icahn School of Medicine, Cambridge Massachusetts, NBC s Today


Moderna's promising coronavirus vaccine is a major beneficiary of the Trump administration's Operation Warp Speed

University of Miami Miller School of Medicine lab tech Sendy Puerto processes blood samples from study participants in the specimen processing lab, Wednesday, Sept. 2, 2020 in Miami. The volunteers are taking part in testing the NIH funded Moderna COVID-19 vaccine. Taimy Alvarez/AP Biotechnology firm Moderna announced promising results from clinical trials of its COVID-19 vaccine candidate on Monday, with its vaccine showing 94.5% efficacy in preventing COVID-19 infections.  Moderna is a ...
Tags: Politics, China, US, Trends, Healthcare, Astrazeneca, Miami, Fda, Pfizer, Vaccine, Oxford University, Donald Trump, Nih, Trump, Johnson Johnson, Department of Health and Human Services HHS


How the biotech upstart Moderna exploded into one of the most important startups of all time, creating a highly effective coronavirus vaccine

Moderna CEO Stephane Bancel attends a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House on March 2, 2020. Andrew Harnik/AP Images In its short corporate history, Moderna has grown accustomed to breaking records.A $450 million funding round in 2015 was a record for the biotech industry. Moderna raised even more the next year. And its 2018 initial public offering was the largest-ever for a biotech, ...
Tags: Health, Science, News, White House, Trends, Healthcare, Pfizer, Donald Trump, Teaser, Biotechnology, Robert Langer, Noubar Afeyan, Moderna, Cabinet Room, Andrew Dunn, Stéphane Bancel


The man in charge of evaluating coronavirus vaccines for the FDA lays out why it will take weeks to vet a COVID-19 shot

FDA's Dr. Peter Marks Amanda Andrade-Rhoades/Getty Images As coronavirus vaccines inch closer to reality, the man in charge of reviewing the approval applications wants Americans to trust the process. That means we're not going to get surprise Food and Drug Administration approvals in the coming days, despite two COVID-19 vaccine frontrunners announcing success over the past week. The review process will be measured in weeks, Dr. Peters Marks, director of the FDA's center for biologica...
Tags: Health, Science, News, Massachusetts, Trends, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Business Insider, EUA, Pharmaceutical, Marks, Steve Parsons, Moderna


Moderna says its coronavirus vaccine is 94.5% effective against COVID-19, a crucial victory in the fight against the pandemic

Moderna Therapeutics seen during COVID-19 in Massachusetts Reuters Moderna's experimental coronavirus vaccine was highly effective at preventing COVID-19, the Massachusetts biotech company said on Monday. The finding comes from a 30,000-person study that compared volunteers who got a two-dose regimen of Moderna's shot to ones who got a placebo. The vaccine was shown to be 94.5% effective in a preliminary analysis. The announcement closely follows similar news from a rival vaccine program b...
Tags: Health, Science, News, Ipo, Massachusetts, US, Trends, Healthcare, Fda, Pfizer, Biotech, Zika, Johnson Johnson, US Food and Drug Administration, Sanofi, Cambridge Massachusetts


The CEO of Moderna says every American will likely have access to a COVID-19 vaccine by June 2021

Moderna CEO Stephane Bancel. Andrew Harnik/AP Images Moderna CEO Stephane Bancel told Business Insider that a coronavirus vaccine will available to any American adult who wants one by June.  The upstart Massachusetts biotech company said Monday that its experimental vaccine was highly effective at preventing COVID-19 in a late-stage study. Bancel shared his prediction for how the next year plays out as vaccines are distributed, including a return to normal in summer 2021 for the US. For mo...
Tags: Health, Science, Massachusetts, US, Trends, Healthcare, Fda, Pfizer, Biotech, Anthony Fauci, Business Insider, Health And Human Services, US Food and Drug Administration, Fauci, EUA, Moderna


Moderna says its coronavirus vaccine works

Hollis Johnson/Business Insider Hello,Another Monday, another dispatch of positive vaccine results. This time: Moderna said its coronavirus vaccine works.Moderna's vaccine is 94.5% effective at preventing COVID-19, the drugmaker said, and it doesn't need to be stored at super-cold temperatures, which could become critical when distributing the shots. Also today in healthcare news: 20 million Americans could get a coronavirus vaccine next month, and why Haven's former COO joined Eden Health...
Tags: Amazon, Texas, Massachusetts, US, Trends, Healthcare, Pfizer, Vaccine, Coo, Evan Vucci, Rose Garden of the White House, Hollis Johnson, Moderna, Andrew Dunn, Moncef Slaoui, JPMorgan Amazon Berkshire Hathaway


Salesforce hired a chief equality officer 4 years ago. Insiders are disappointed with the slow progress.

Hello everyone! Welcome to this weekly roundup of Business Insider stories from co-Editor in Chief Matt Turner. Subscribe here to get this newsletter in your inbox every Sunday.Read on for more on Salesforce insiders saying diversity progress has been slow, former employers claiming a "boys' club" culture at elite law firm Jones Day, and Pfizer's vaccine feat.  (L to R) Tony Prophet, Salesforce chief equality and recruiting officer and Marc Benioff, Salesforce CEO and cofounder Steve Jenning...
Tags: Utah, Pinterest, Microsoft, Washington, White House, US, San Francisco, Trends, Georgia, Joe Biden, Cnn, New York Times, Connecticut, Larry Ellison, Silicon Valley, Goldman Sachs


20 million Americans could get a coronavirus vaccine next month, according to the head of Operation Warp Speed

Dr. Moncef Slaoui, chief adviser to Operation Warp Speed, speaks in the Rose Garden of the White House, Friday, Nov. 13, 2020, in Washington. AP Photo/Evan Vucci 20 million Americans could receive a coronavirus vaccine in December, the top scientist involved in the US government's vaccine initiative said Friday. Moncef Slaoui said 25 million to 30 million Americans could be immunized each month after that.  That timeline is based on success for two leading vaccine candidates and a speedy c...
Tags: Health, Politics, Science, Washington, White House, US, Trends, Healthcare, Food And Drug Administration, Astrazeneca, Pfizer, Biotech, Anthony Fauci, Health And Human Services, Johnson Johnson, Sanofi


We got the vaccine news the world was waiting on this week

Hollis Johnson/Business Insider Hello, What a week it's been. While markets and public health experts have been optimistic about the results of Pfizer's coronavirus vaccine, it's hard to ignore the uncontrolled spread of the virus around most states in the US.It's making planning for the holidays even harder. Hope y'all are having an OK time navigating smaller festivities and potentially difficult conversations with loved ones with different appetites for COVID-19 risk. We'll get into all ...
Tags: Amazon, UK, Supreme Court, Digital, US, Trends, Turkey, Healthcare, Food And Drug Administration, National Health Service, National Institutes of Health, Salaries, Pfizer, Vaccine, Jeff Bezos, Nih


Meet the married billionaire couple who helped create the Pfizer vaccine

Dr. Ugur Sahin and Dr. Özlem Türeci. Stefan F. So¤mmer via www.imago-images.de/Reuters A German couple is one of the driving forces behind Pfizer's historic coronavirus vaccine. Dr. Ugur Sahin is the CEO and Dr. Özlem Türeci the chief medical officer of BioNTech, the company that created the vaccine in partnership with Pfizer. The couple crossed the billionaire threshold in June, when BioNTech shares surged on news of its pact with Pfizer, and a recent surge off the positive vaccine news ...
Tags: Germany, Trends, Turkey, Cologne, New York Times, Tokyo, Pfizer, Times, Istanbul, Wuhan, Cdu, Reuters, Thomas, Welt am Sonntag, Jens Spahn, Sahin


Pfizer's plan to solve its vaccine's cold storage problem

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,Today in healthcare news: Pfizer's already thinking about a new version of its vaccine that solves a key problem, the seven ways Amazon's taking on the $3.6 trillion healthcare industry, and people are going back to the doctor, health insurers' Q3 earnings show.  Oi...
Tags: Health, Amazon, Trends, North Dakota, Pfizer, Donald Trump, Donald Trump Jr, Andrew Dunn, BLAKE DODGE, Lydia Ramsey Pflanzer, Lydia Read, Shelby Livingston, Dado Ruvic Reuters Pfizer, Hollis Johnson Business Insider Amazon


Pfizer's coronavirus vaccine requires 2 shots given 3 weeks apart, which could make distribution more complicated

A volunteer receives an experimental vaccine for the coronavirus as part of a Pfizer clinical trial at the University of Maryland. University of Maryland Pfizer's coronavirus vaccine candidate is more than 90% effective in preventing COVID-19, the company announced Monday.  The vaccine involves two shots administered three weeks apart. People may later need additional booster shots too, experts say. Visit Business Insider's homepage for more stories. Pfizer's coronavirus vaccine candidate ...
Tags: Health, Science, News, Trends, Turkey, Food And Drug Administration, HPV, Astrazeneca, Pfizer, Vaccines, Seattle, Mount Sinai, Icahn School of Medicine, ORENSTEIN, Moderna, Thomas Peter Reuters